Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:aimsTo |
improve patient outcomes
|
| gptkbp:collaboratesWith |
research institutions
|
| gptkbp:conducts |
clinical trials
|
| gptkbp:develops |
medications for mental health disorders
|
| gptkbp:employs |
scientists
regulatory affairs specialists clinical researchers |
| gptkbp:focusesOn |
neuroscience research
|
| gptkbp:hasAwards |
industry accolades
|
| gptkbp:hasCollaborationsWith |
government agencies
biotechnology firms |
| gptkbp:hasFocusOn |
precision medicine
|
| gptkbp:hasLocalCuisine |
new psychiatric drugs
|
| gptkbp:hasParticipatedIn |
over 150 countries
|
| gptkbp:hasPartnershipsWith |
non-profit organizations
academic institutions |
| gptkbp:hasProductLine |
in the field of psychiatry
|
| gptkbp:hasResearchInterest |
gptkb:schizophrenia
Alzheimer's disease Parkinson's disease depression neurodegenerative diseases bipolar disorder cognitive disorders |
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Neuroscience
|
| gptkbp:isActiveIn |
global markets
|
| gptkbp:isDedicatedTo |
sustainability
mental health research |
| gptkbp:isEngagedIn |
mental health awareness campaigns
healthcare_innovation |
| gptkbp:isFocusedOn |
patient-centered care
|
| gptkbp:isHeadquarteredIn |
gptkb:Titusville,_New_Jersey
|
| gptkbp:isInvolvedIn |
community outreach programs
patient advocacy clinical development healthcare_policy_advocacy biomarker_discovery drug_discovery |
| gptkbp:isKnownFor |
innovative therapies
patient engagement strategies |
| gptkbp:isPartOf |
gptkb:Johnson_&_Johnson's_pharmaceutical_segment
|
| gptkbp:isRecognizedFor |
scientific contributions
leadership in neuroscience |
| gptkbp:offers |
educational resources
|
| gptkbp:participatesIn |
conferences
|
| gptkbp:partOf |
gptkb:Johnson_&_Johnson
|
| gptkbp:supports |
mental health initiatives
|
| gptkbp:utilizes |
advanced technologies
|
| gptkbp:wasFoundedIn |
2009
|